Serum hepcidin levels are associated with serum triglycerides and interleukin-6 concentrations in patients with end-stage renal disease

Therapeutic Apheresis and Dialysis

Volumn 18, Issue 3, 2014, Pages 279-283

  Samouilidou, Elisabeth ^a   Pantelias, Konstantinos ^b   Petras, Dimitrios ^c   Tsirpanlis, George ^c   Bakirtzi, Joulia ^c   Chatzivasileiou, George ^d   Tzanatos, Helen ^b   Grapsa, Eirini ^b  

^a ALEXANDRA HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c IASO GENERAL HOSPITAL   (Greece)

^d Renal Dialysis Unit Protipo Nefrologiko Kentro Athinon   (Greece)

Author keywords

Atherosclerosis; Hemodialysis; Hepcidin; Inflammation; Peritoneal dialysis

Indexed keywords

ALBUMIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; FERRITIN; HEPCIDIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UREA;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; END STAGE RENAL DISEASE; FEMALE; FERRITIN BLOOD LEVEL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HORMONE BLOOD LEVEL; HUMAN; INFLAMMATION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; AGE; AGED; BLOOD; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; PROCEDURES; REGRESSION ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY;

ADULT; AGE FACTORS; AGED; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; HEPCIDINS; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; REGRESSION ANALYSIS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; TRIGLYCERIDES;

EID: 84903314741     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/1744-9987.12102     Document Type: Article

References (17)

1. Kemna E, Tjalsma H, Willemns H, Swinkels D. Hepcidin: from discovery to differential diagnosis. Hematologica 2008;93:90-97.
2. Nemeth E, Tuttle MS, Powelson J etal. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2090-2091.
3. Mayszko J, Malyszko JK, Pawlak K, Mysliwiec M. Hepcidin, iron, status, and renal function in chronic renal failure, kidney transplantation and hemodialysis. Am J Hematol 2006;81:832-837.
4. Kuragano T, Shimonaka Y, Kida A, Furata M etal. Determinants of hepcidin in patients on maintenance hemodialysis: role of inflammation. Am J Nephrol 2010;31:534-540.
5. Kuragano T, Itoh K, Shimonaka Y, Kida A etal. Hepcidin as well as TNFα are significant predictors of arterial stiffness in patients on maintenance hemodialysis. Nephrol Dial Tranplant 2011;26:2663-2667.
6. Sullivan J. Macrophage iron, hepcidin and atherosclerotic plaque stability. Exp Biol Med 2007;232:1014-1020.
7. Zimmermann A, Zimmermann T, Schattenberg J, Pöttgen S etal. Alteration in lipid, carbohydrate and iron metabolism in patients with non-alcoholic steatohepatitis (NASH) and metabolic syndrome. Eur J Intern Med 2011;22:305-310.
8. Arabul M, Gullulu M, Yilmaz Y, Akdag I etal. Effect of fluvastatin on serum prohepcidin levels in patients with end-stage renal disease. Clin Biochem 2008;41:1055-1058.
9. Li XY, Chang JP, Su ZW, Li JH etal. How does short-term low dose stimvastatin influences serum prohepcidin levels in patients with end-stage renal disease? A pilot study. Therap Apher Dial 2010;14:308-314.
10. Samouilidou E, Karpouza A, Kostopoulos V, Bakirtzi T etal. Lipid abnormalities and oxidized LDL in chronic kidney disease patients on hemodialysis and peritoneal dialysis. Renal Fail 2012;34:160-164.
11. Xu Y, Ding XQ, Zou JZ, Liu ZH, Jiang SH, Chen YM. Serum hepcidin in haemodialysis patients: associations with iron status and microinflammation. J Intern Med Res 2011;39:1961-1964.
12. Zaritsky J, Young B, Wang HJ etal. Hepcidin-A potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol 2009;4:1051-1056.
13. Darshan D, Anderson G. Interacting signals in the control of hepcidin expression. Biometals 2009;22:77-87.
14. Nemeth E, Valore E, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003;101:2461-2463.
15. Mayszko J, Malyszko JK, Hryszko T, Pawlak K, Mysliwiec M. Is hepcidin a link between anemia, inflammation and liver function in hemodialysed patients? Am J Nephrol 2005;25:586-590.
16. Ford B, Eby C, Scott M, Coyne D. Intra-individual variability in serum hepcidin precludes its use as marker of iron status in hemodialysis patients. Kidney Int 2010;78:769-773.
17. Galesloot T, Vermeulen S, Geurts-Moespot A etal. Serum hepcidin: reference ranges and biochemical correlates in general population. Blood 2011;117:e218-225.